Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

J. Jack Lee

Professor

The University of Texas MD Anderson Cancer Center

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

40%

Biostatistics

30%

Oncology

60%

Cancer Therapy

50%

Cancer Biology

30%

Pharmacoepidemiology

20%

Colorectal Cancer

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy

Article Link

Year:

2024

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer

Article Link

Year:

2023

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival

Article Link

Year:

2023

Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer

Article Link

Year:

2023

Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival

Article Link

Year:

2022

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

Article Link

Year:

2022

Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy

Article Link

Year:

2022

Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19

Article Link

Year:

2022

Chronic Exposure to Waterpipe Smoke Elicits Immunomodulatory and Carcinogenic Effects in the Lung

Article Link

Year:

2022

Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer

Article Link

Year:

2022

IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves

Article Link

Year:

2021

Collaborators21

Janos Roszik

The University of Texas MD Anderson Cancer Center

UNITED STATES

Jianjun Zhang

The University of Texas MD Anderson Cancer Center

UNITED STATES

Meghna Trivedi

Assistant Professor

Columbia University Irving Medical Center

UNITED STATES

Ahsan Farooqi

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Anisha Patel

The University of Texas MD Anderson Cancer Center

UNITED STATES

Martin D. Berger

SWITZERLAND

Giuseppe Masucci

Karolinska Institutet

SWEDEN

Jason D. Wright

UNITED STATES

Marc Van den Eynde

Associate Professor

Université catholique de Louvain

BELGIUM

Judy Garber

Chief, Division of Cancer Genetics and Prevention

Dana-Farber Cancer Institute

UNITED STATES

Inti Zlobec

University of Bern

SWITZERLAND

Carolyn J. Presley

UNITED STATES

Jiexin Zhang

The University of Texas MD Anderson Cancer Center

UNITED STATES

Ethan Ludmir

UNITED STATES

Luigi Laghi

Associate professor of gastroenterology

University of Parma

ITALY

Toshihiko Torigoe

Professor

Sapporo Medical University

JAPAN

David Jaffray

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Don L. Gibbons

The University of Texas MD Anderson Cancer Center

UNITED STATES

Jia Wu

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Maria Gabriela Raso

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Kristýna Němejcová

Všeobecná Fakultní Nemocnice v Praze

CZECH REPUBLIC

How do I reach out?

Meet Kite AI